Cancer Management in Saudi Arabia: Recommendations by the Saudi Oncology HeAlth Economics ExpeRt GrouP (SHARP)

Saudi Pharmaceutical Journal

Hana Alabdulkarim¹  Mohammed Bakkar²  Hajer Almodaheem²  Shouki Bazarbashi³  Nora Alkhudair⁴  Mohammed Alnahedh⁵  Fouad Alnajjar⁶  Mohammad Alawagi⁷  Hadeel Samarkandi⁸  Ahmed Al-jedai⁸  Hashem Alhashem⁸  Majed Alshamrani⁹  Feras Alfraih^1,10  Mai Alsaqaaby^1,11 

[1] Alfaisal University, College of Pharmacy, Riyadh, Saudi Arabia;Research Center, Riyadh, Saudi Arabia;Clinical Pharmacy Department, King Fahad Medical City, Riyadh, Saudi Arabia;Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia;Department of Oncology, King Saud Medical City, Riyadh, Saudi Arabia;Drug Policy and Economic Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia;King Abdullah Center of Oncology and Liver Disease, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;;Pharmaceutical Care Division, King Faisal Specialist Hospital &Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia;Prince Mohammed Bin Nasser Hospital, Jazan, Saudi Arabia;Therapeutic Affairs Deputyship, Ministry of Health, Riyadh, Saudi Arabia Pharmaceutical Care Services, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia;

关键词: Oncology;    Cancer;    Saudi;    Economics;    Pharmacoeconomics;    Pharmacy;   

DOI  :  

来源: DOAJ

【 摘 要 】

Cancer is widely recognized as a major global health problem and is estimated to rank as one of the leading causes of death worldwide. Saudi Arabia has undergone remarkable socioeconomic development in the past 40 years which has contributed to the increase in cancer incidence. The high costs of new oncology medications in combination with uncertainty of long-term effectiveness and safety outcomes highlight the importance of considering value, in terms of clinical outcomes, relative to cost. We convened a group of experts to discuss key factors impacting the current state of cancer management in Saudi Arabia and to agree on a list of recommendations, with a focus on value-based care, considering evidence, patients, and costs.

【 授权许可】

Unknown